additional biopsies

PROCEDURE4 trials

Sponsors

University of Pennsylvania, Centre Hospitalier Universitaire de Nice, Rennes University Hospital, Abeona Therapeutics, Inc

Conditions

Crohn DiseaseDigestive System DiseasesDystrophic Epidermolysis Bullosa (DEB)Epidermolysis Bullosa (EB)Inflammatory Bowel Disease, Ulcerative Colitis TypeNon-ischemic CardiomyopathyRecessive Dystrophic Epidermolysis Bullosa (RDEB)Scleroderma, Systemic

Phase 4

Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds

Not yet recruitingNCT07717736

Abeona Therapeutics, IncDystrophic Epidermolysis Bullosa (DEB), Epidermolysis Bullosa (EB), Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Start: 2026-11-01End: 2032-07-01Target: 100Updated: 2026-08-06

Unknown Phase

Electrogram-Guided Myocardial Advanced Phenotyping

TerminatedNCT03293381

University of PennsylvaniaNon-ischemic Cardiomyopathy

Start: 2018-11-30End: 2024-11-30Updated: 2025-04-06

microRNAs in Systemic Scleroderma

CompletedNCT04148716

Centre Hospitalier Universitaire de NiceScleroderma, Systemic

Start: 2021-01-11End: 2022-12-22Updated: 2024-06-27

Intestinal Organoids

RecruitingNCT05294107

Rennes University HospitalCrohn Disease, Digestive System Diseases, Inflammatory Bowel Disease, Ulcerative Colitis Type

Start: 2022-09-06End: 2028-03-07Target: 90Updated: 2026-06-17

Related Papers

Unipolar Voltage Mapping to Predict Recovery of Left Ventricular Ejection Fraction in Patients With Recent-Onset Nonischemic Cardiomyopathy

Circulation2024-11-142 citations